journal article·2015-09-16

In Vitro Model of a Fibrosa Layer of a Heart Valve

Soumen Jana, Amir Lerman, Robert D Simari

Publisher page

Abstract

The fibrosa layer of a cardiac aortic valve is composed mostly of a dense network of type I collagen fibers oriented in circumferential direction. This main layer bears the tensile load and responds to the high stress on a leaflet. The inner fibrosa layer is also the site of pathophysiologic changes that result in valvular dysfunction, including stenosis and regurgitation. In vitro studies of these changes are limited by the absence of a substrate that mimics the circumferentially oriented structure of the fibrosa layer. In heart valve tissue engineering, generation of this layer is challenging. This study aimed to develop an artificial fibrosa layer of a native aortic leaflet. A unique morphologically biomimicked, pliable, but standalone substrate with circumferentially oriented nanofibers was fabricated by electrospinning on a novel collector designed for this study. The substrate had low-bulk tensile stiffness and ultimate strength; thus, cultured valvular interstitial cells (VICs) showed a fibroblast phenotype that is generally observed in a healthy aortic leaflet. Furthermore, gene and protein expression and morphology of VICs in substrates were close to those in the fibrosa layer of a native aortic leaflet. This artificial fibrosa layer can be useful for in vitro studies of valvular dysfunctions.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cardiac Valve Diseases and Treatments · Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, United States

School of Medicine, University of Kansas, 3901 Rainbow Boulevard, Kansas City, Kansas 66160, United States

Funding

Center for Regenerative Medicine, Mayo Clinic · Grainger Foundation · HH Sheikh Hamed bin Zayed Al Nahyan Program in Biological Valve Engineering

References (53)

Show source-provided references
1. 10.1016/S0140-6736(10)62196-410.1016/S0140-6736(10)62196-4 ↗
2. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health;Fuster, V.; Kelly, B. B., Eds. National Academies Press:Washington, D.C., 2010; p484.
3. 10.1016/j.jconrel.2014.10.00910.1016/j.jconrel.2014.10.009 ↗
4. 10.1002/term.201010.1002/term.2010 ↗
5. 10.1161/CIRCINTERVENTIONS.112.97102810.1161/CIRCINTERVENTIONS.112.971028 ↗
6. 10.1007/s11239-012-0710-110.1007/s11239-012-0710-1 ↗
7. 10.1161/CIRCULATIONAHA.104.48673810.1161/CIRCULATIONAHA.104.486738 ↗
8. 10.1254/jphs.13R05CR10.1254/jphs.13R05CR ↗
9. 10.1089/ten.2006.12.90510.1089/ten.2006.12.905 ↗
10. 10.2353/ajpath.2007.07025110.2353/ajpath.2007.070251 ↗
11. 10.1016/S0002-9440(10)62520-510.1016/S0002-9440(10)62520-5 ↗
12. 10.1634/stemcells.2004-001310.1634/stemcells.2004-0013 ↗
13. 10.1115/1.276811110.1115/1.2768111 ↗
14. 10.1073/pnas.130636911010.1073/pnas.1306369110 ↗
15. 10.1021/am301803b10.1021/am301803b ↗
16. 10.1088/1758-5082/6/3/03501210.1088/1758-5082/6/3/035012 ↗
17. 10.1039/c3tb20197j10.1039/c3tb20197j ↗
18. 10.1016/j.progpolymsci.2010.04.00210.1016/j.progpolymsci.2010.04.002 ↗
19. 10.1002/adhm.20130009210.1002/adhm.201300092 ↗
20. 10.1039/c3tb20825g10.1039/c3tb20825g ↗
21. 10.1155/2014/80243510.1155/2014/802435 ↗
22. 10.1016/j.biomaterials.2014.04.03910.1016/j.biomaterials.2014.04.039 ↗
23. 10.5402/2012/16136410.5402/2012/161364 ↗
24. 10.1016/S0003-4975(10)63984-710.1016/S0003-4975(10)63984-7 ↗
25. 10.1115/1.42962410.1115/1.429624 ↗
26. 10.1161/01.RES.0000136520.07995.aa10.1161/01.RES.0000136520.07995.aa ↗
27. 10.1161/CIRCRESAHA.113.30015310.1161/CIRCRESAHA.113.300153 ↗
28. 10.1089/ten.tea.2012.036510.1089/ten.tea.2012.0365 ↗
29. 10.1161/CIRCULATIONAHA.105.59176810.1161/CIRCULATIONAHA.105.591768 ↗
30. 10.1371/journal.pone.005586710.1371/journal.pone.0055867 ↗
31. 10.3109/03008207.2013.82395410.3109/03008207.2013.823954 ↗
32. 10.1016/j.ymeth.2008.01.00410.1016/j.ymeth.2008.01.004 ↗
33. 10.4161/biom.2272310.4161/biom.22723 ↗
34. 10.1016/j.jbiomech.2008.06.03110.1016/j.jbiomech.2008.06.031 ↗
35. 10.1016/j.actbio.2014.03.01410.1016/j.actbio.2014.03.014 ↗
36. 10.1038/nmat362710.1038/nmat3627 ↗
37. 10.1002/jbmr.38210.1002/jbmr.382 ↗
38. 10.1186/1755-1536-6-1510.1186/1755-1536-6-15 ↗
39. 10.1007/s10439-011-0273-x10.1007/s10439-011-0273-x ↗
40. 10.1016/S0014-5793(01)02737-510.1016/S0014-5793(01)02737-5 ↗
41. 10.1016/S0003-4975(02)04706-910.1016/S0003-4975(02)04706-9 ↗
42. 10.1016/S0003-4975(00)01979-210.1016/S0003-4975(00)01979-2 ↗
43. 10.1161/CIRCULATIONAHA.110.00676710.1161/CIRCULATIONAHA.110.006767 ↗
44. 10.1016/j.biomaterials.2013.10.08010.1016/j.biomaterials.2013.10.080 ↗
45. 10.1166/jbt.2013.110510.1166/jbt.2013.1105 ↗
46. 10.1016/S0955-0674(02)00364-210.1016/S0955-0674(02)00364-2 ↗
47. 10.1016/j.biomaterials.2009.05.04910.1016/j.biomaterials.2009.05.049 ↗
48. 10.1016/j.biomaterials.2012.01.01010.1016/j.biomaterials.2012.01.010 ↗
49. 10.1016/j.actbio.2013.03.04210.1016/j.actbio.2013.03.042 ↗
50. 10.3390/fib202015810.3390/fib2020158 ↗
51. 10.1083/jcb.20050617910.1083/jcb.200506179 ↗
52. 10.1038/sj.jid.570061310.1038/sj.jid.5700613 ↗
53. 10.1002/jbm.b.3318610.1002/jbm.b.33186 ↗